MED 7 LLC AND HEMPCO IC. ANNOUNCE THE PUBLICATION OF THE FIRST PROSPECTIVE HUMAN CLINICAL TRIAL USING A CBD-RICH FULL-SPECTRUM HEMP OIL IN PATIENTS WITH COVID-19
Bluffdale, UT, May 12, 2022 – Med 7, LLC (www.Med 7cbd.com), and HempCo, Inc., Lone Tree, CO, announce the completion and publication of the first prospective human clinical study to assess the effects of a CBD-rich full-spectrum hemp oil in patients with COVID-19 (SARS-CoV-2). The study used Med 7, a full-spectrum hemp product made with…
Med 7 LLC, announces the completion of a Sleep Study using Hempzorb81™ Full Spectrum Hemp Oil
BLUFFDALE, Utah, Oct. 1, 2021 /PRNewswire/ — Med 7, LLC (www.Med 7cbd.com) and HempCo, Inc. announce the completion of a human clinical study to assess the effects of Med 7 on sleep. Med 7 is a full spectrum hemp product made with Purzorb® technology, now trademarked as Hempzorb81. “Over 30 million Americans suffer from sleep issues affecting work…
Med 7 llc, announce the completion of a safety and efficacy study using hempzorb81™ full spectrum oil in patients with type ii diabetes
BLUFFDALE, Utah, April 29, 2021 /CNW/ — Med7, LLC (www.Med7cbd.com) and HempCo, Inc. announce the completion of a human clinical study in patients with Type II Diabetes using Purzorb® technology, now trademarked as Hempzorb81TM. “This study will provide our customers and providers with evidence based products not seen to this point in the Industrial Hemp and CBD market place,”…
PurHealthRX® Announces Completion of the First Major Non-pharmaceutical CBD Study in Humans
LAS VEGAS, NV – PurHealthRX® announced the completion of the first major clinical study looking at the anti-aging effects and safety of full spectrum hemp CBD oil in human subjects. The study was completed with support from the National Institute of Health (NIH). The randomized placebo-controlled study on 150 patients showed that full spectrum hemp…